Review of biologic or JAK inhibitor treatment
at least every 12 months
tests per year, UK, at least every 12 months
“People should be reassessed at least every 12 months to decide whether treatment should continue.”
NICE NG130, Ulcerative colitis: management, section 1.2, 2019-05
- Kind of source
- Clinical guideline
- Read on
- 2026-11-06
- Daily check
- Quote found at the source on 2026-11-06
- What to know
- Applies to the medicines in recommendations 1.2.15 to 1.2.19.
Used in
Kept as evidence; no figure on the platform is computed from it yet.